Hims House

In episode 10 of Hims House, Jonathan Stern, Louis Stevens, and Dr. H interview Sekander Amini, a UK-based pharmacist and long-time Hims investor. Sekander shares insights about how his pharmacy mirrors Hims' model by offering premium services like mental health and weight loss medications. He highlights Hims' advantages in compounding medications, simplifying treatment adherence, and leveraging technology for better patient care. The group discusses the healthcare landscape in the UK, touching on public versus private care and the potential growth opportunity for Hims. They also explore Hims' focus on premium experiences, the role of AI in healthcare, and what investors should watch for in the upcoming earnings call.00:00 Introduction and Sekander Amino Welcome00:52 Day-to-Day at the Private Pharmacy03:24 Initial Investment in Hims03:51 Hims' Price Transparency and Accessibility05:46 Compounded Medications and Personalized Care07:07 Premium Experience and Product Evolution15:59 Comparing UK and US Healthcare Systems20:53 Opportunities in the UK Market23:09 Hims' Generic Offerings23:30 UK Healthcare System Overview24:19 Hims' Market Potential in the UK24:48 Compounding Pharmacies in the UK25:40 Challenges in International Expansion27:10 Hims' Strategic Focus34:18 MedMatch and Mental Health40:14 International Expansion Concerns44:09 Q3 Earnings Expectations45:54 Closing Remarks and Farewell Get full access to Hims House at himshouse.substack.com/subscribe

In Episode 9 of Hims House, Jonathan Stern, Louis Stevens, and Dr. H discuss potential product expansions for Hims & Hers, focusing on menopause, testosterone, fertility, and diabetes. They highlight menopause as a low-hanging opportunity due to minimal medical oversight requirements, while testosterone presents logistical challenges with necessary blood testing and monitoring. The conversation delves into Hims' methodical product rollout strategy, suggesting that they time launches carefully to ensure consistent growth. The episode also explores Hims' use of vertical integration with its 503B compounding facility and the potential implications of their recent inclusion in the S&P Small Cap 600 index.(00:00) - Introduction(00:42) - Menopause as an opportunity(03:33) - Testosterone overview(06:10) - Diabetes Management and Livongo Comparison(10:45) - Logistical Challenges with Testosterone Treatment(24:03) - 503B Compounding Facility Now Hiring(29:24) - Hims Moneyball Comparison(34:52) - Weight Watchers GLP-1 Offering and Impact on Hims(38:55) - Inclusion in S&P Small Cap 600Website: https://himshouse.comTwitter/X: @himshouseDiscord: https://discord.gg/WPzMX448V8Jonathan Stern - @jonathanrsternLouis Stevens - @LA_stevens_Dr. H - @stayathomedoc Get full access to Hims House at himshouse.substack.com/subscribe

A deep dive into the financial health of a leading telehealth company reveals impressive subscriber growth, reaching nearly 2 million. Personalized medications are driving retention and shaping a sustainable business model. The discussion emphasizes the balance between customer acquisition costs and cash flow, highlighting significant metrics such as gross profit and average revenue per user. Despite concerns about marketing spend, the company emerges as a strong long-term investment, outperforming expectations in a competitive market.

In episode 7 of Hims House, Jonathan, Louis, and Dr. H discuss the evolving telehealth industry, focusing on the market size, adoption trends, and why Hims & Hers is emerging as a leader in the space. Dr. H highlights how the ease of use and streamlined digital healthcare experience has allowed Hims to outpace competitors. The conversation also delves into the challenges of integrating insurance and how Hims' decision to avoid insurance might be an advantage, as it keeps the process simple and cost-effective. They compare Hims to its competitors like Ro and Teladoc, discussing pricing, market share, and the potential for industry consolidation. The episode concludes by touching on the potential regulatory and competitive threats from large companies like Amazon and Walmart.(00:00) - Introduction(00:59) - Market size and telehealth growth(01:35) - The evolution of digital healthcare(02:16) - Why Hims does not accept insurance(03:27) - Comparison with Teladoc's insurance model(05:00) - Hims & Hers business appeals to millennials(08:38) - Total Addressable Market (TAM) discussion(12:02) - Pricing comparison between Hims and competitors(14:07) - Telehealth industry consolidation vs. fragmentation(22:30) - Winner take most?(23:46) - The impact of regulations on GLP-1s and Hims(27:22) - Amazon and other behemoths entering the marketWebsite: https://himshouse.comTwitter/X: @himshouseDiscord: https://discord.gg/WPzMX448V8Jonathan Stern - @jonathanrsternLouis Stevens - @LA_stevens_Dr. H - @stayathomedoc Get full access to Hims House at himshouse.substack.com/subscribe

In this episode of Hims House, the hosts discuss the importance of Hims's partnerships with healthcare providers, including doctors, nurse practitioners, and pharmacies. Dr. H shares his experience joining Hims, describing the onboarding process and the evolving role of nurse practitioners. The team explores Hims's vertical integration strategy, focusing on the acquisition of 503A and 503B pharmacies, which allows the company to streamline production and reduce costs. They also touch on future trends, including AI's role in healthcare, and conclude with the challenges of improving shipping and fulfillment logistics for Hims's products.(00:00) - Introduction  (00:38) - Dr. H's Journey to Joining Hims  (02:47) - Doctor Autonomy and Guidelines at Hims  (04:40) - Leaving Hims and Evolution Towards More Nurse Practitioners(06:04) - AI's Role in Medicine and Hims Operations  (13:31) - 503A vs 503B Pharmacies Explained  (16:37) - Hims Acquisitions: Apostrophe and Honest Health  (23:33) - Acquisition of Medisource RX and Addressing the Hunterbrook Short Report  (28:11) - Fulfillment, Distribution, and Logistics Partnerships  (32:31) - Shipping Issues, Customer Concerns, and Last Mile DeliveryWebsite: https://himshouse.comTwitter/X: @himshouseDiscord: https://discord.gg/WPzMX448V8Jonathan Stern - @jonathanrsternLouis Stevens - @LA_stevens_Dr. H - @stayathomedoc Get full access to Hims House at himshouse.substack.com/subscribe

In this episode of Hims House, Jonathan Stern, Louis Stevens, and Dr. H walk through the Hims customer experience, focusing on the weight management intake process. They explore the thoroughness of the signup flow, emphasizing how it mimics a traditional doctor’s visit while countering claims made in a Hunterbrook short report. Dr. H provides insights into how the system assesses customer data and adapts treatments, comparing the ease of Hims' virtual experience to the inefficiencies of the legacy healthcare system. They conclude by discussing customer support, logistics, and overall satisfaction, noting that most users are happy and appreciate the platform's convenience.(00:00) - Welcome to Hims House(00:45) - Dr. H starts the weight loss signup flow(01:15) - Discussion on the short report by Hunterbrook(10:50) - GLP-1s and blood tests(11:30) - Could Hims displace primary care physicians?(14:33) - Hims as a multi-product platform(17:29) - Certificate of Analysis (COA)(18:59) - Consultation with a doctor(21:48) - Hims patient queuing system(22:46) - Contrasting the Hims experience with the legacyhealthcare system(25:39) - Timeline and cost comparisons: Hims vs. legacy system(27:35) - Hims price bundling: doctor + prescription all in one(28:17) - Hims Net Promoter Score (NPS) and customer satisfactionWebsite: https://himshouse.comTwitter/X: @himshouseDiscord: https://discord.gg/WPzMX448V8Jonathan Stern - @jonathanrsternLouis Stevens - @LA_stevens_Dr. H - @stayathomedoc Get full access to Hims House at himshouse.substack.com/subscribe

In this episode of Hims House, Jonathan, Louis, and Dr. H dive into Hims & Hers product offerings, discussing key categories like sexual health, mental health, hair loss, weight management, and skincare. They highlight the success of products like ED and hair loss treatments, which remain highly popular, while newer categories such as weight management have seen rapid growth. Dr. H emphasizes the potential future focus on testosterone and menopause treatments, as well as personalized medicine to improve patient outcomes. The team also explores the competitive landscape, touching on how Hims has outperformed rivals like Ro, particularly in launching a successful women’s brand, Hers. Finally, they discuss the importance of execution and branding in maintaining Hims' market leadership.(00:00) - Introduction(00:19) - Hims Product Pillars Overview  (01:00) - Most Popular Product Categories  (02:11) - Future Product Offerings: Testosterone & Menopause?(05:56) - Personalized Treatments Explained  (12:00) - Hims Moat and Stickiness(18:42) - Dr. H on Hims’ Brand Moat(23:47) - Hims vs. Competitors: Roman and Rory  (25:12) - Hers Brand Success and Future Potential   (32:46) - Differences Between Male and Female Health ApproachesWebsite: https://himshouse.comTwitter/X: @himshouseDiscord: https://discord.gg/WPzMX448V8Jonathan Stern - @jonathanrsternLouis Stevens -  @LA_stevens_Dr. H -  @stayathomedoc Get full access to Hims House at himshouse.substack.com/subscribe

Louis Stevens, a business expert in healthcare, joins Dr. H, a physician with insights on the medical field, to discuss the remarkable journey of Hims & Hers Health. They delve into how CEO Andrew Dudum's vision is reshaping healthcare access and affordability. The duo compares Hims to Uber, emphasizing its disruptive potential through vertical integration and innovative technology. Dr. H outlines the challenges in the U.S. system, while they share confidence that Hims will excel in chronic care management, transforming patient experiences.

Discover the innovative business model of Hims & Hers, offering discreet healthcare solutions. The patient experience is explored, highlighting the blend of technology and personalized care. They delve into the complexities of prescription management for sensitive health conditions and the challenges of urgent care navigation. The discussion touches on the potential of AI and technology in shaping the future of healthcare. Learn about groundbreaking pharmaceuticals, like combining medications for erectile dysfunction and heart health, showcasing new approaches to treatment.

Dr. H, a board-certified physician in telemedicine, and Louis Stevens, an equity analyst with deep knowledge of Hims & Hers, dive into the company's unique cash-based healthcare model. They discuss how Hims bypasses traditional insurance barriers, offering affordable medications and personalized care. The duo highlights Hims' rapid growth in the weight loss market, achieving success without relying on GLP-1 treatments. They also explore the emotional aspects of patient care and the challenges faced by big corporations in adopting this innovative approach.